Immunomodulatory effects of stem cells

Therapeutic option for neurodegenerative disorders

Martin Caprnda, Peter Kubatka, Katarina Gazdikova, Iveta Gasparova, Vanda Valentova, Nadezda Stollarova, Giampiero La Rocca, Nazarii Kobyliak, Jozef Dragasek, Ioana Mozos, Robert Prosecky, Dario Siniscalco, Dietrich Busselberg, Luis Rodrigo, Peter Kruzliak

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Stem cells have the capability of self-renewal and can differentiate into different cell types that might be used in regenerative medicine. Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) currently lack effective treatments. Although stem cell therapy is still on the way from bench to bedside, we consider that it might provide new hope for patients suffering with neurodegenerative diseases. In this article, we will give an overview of recent studies on the potential therapeutic use of mesenchymal stem cells (MSCs), neural stem cells (NSCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and perinatal stem cells to neurodegenerative disorders and we will describe their immunomodulatory mechanisms of action in specific therapeutic modalities.

Original languageEnglish
Pages (from-to)60-69
Number of pages10
JournalBiomedicine and Pharmacotherapy
Volume91
DOIs
Publication statusPublished - 1 Jul 2017

Fingerprint

Neurodegenerative Diseases
Stem Cells
Induced Pluripotent Stem Cells
Regenerative Medicine
Neural Stem Cells
Amyotrophic Lateral Sclerosis
Therapeutic Uses
Embryonic Stem Cells
Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Multiple Sclerosis
Parkinson Disease
Alzheimer Disease
Therapeutics

Keywords

  • Neurodegenerative disorders
  • Regenerative medicine
  • Stem cell therapy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Caprnda, M., Kubatka, P., Gazdikova, K., Gasparova, I., Valentova, V., Stollarova, N., ... Kruzliak, P. (2017). Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders. Biomedicine and Pharmacotherapy, 91, 60-69. https://doi.org/10.1016/j.biopha.2017.04.034

Immunomodulatory effects of stem cells : Therapeutic option for neurodegenerative disorders. / Caprnda, Martin; Kubatka, Peter; Gazdikova, Katarina; Gasparova, Iveta; Valentova, Vanda; Stollarova, Nadezda; La Rocca, Giampiero; Kobyliak, Nazarii; Dragasek, Jozef; Mozos, Ioana; Prosecky, Robert; Siniscalco, Dario; Busselberg, Dietrich; Rodrigo, Luis; Kruzliak, Peter.

In: Biomedicine and Pharmacotherapy, Vol. 91, 01.07.2017, p. 60-69.

Research output: Contribution to journalReview article

Caprnda, M, Kubatka, P, Gazdikova, K, Gasparova, I, Valentova, V, Stollarova, N, La Rocca, G, Kobyliak, N, Dragasek, J, Mozos, I, Prosecky, R, Siniscalco, D, Busselberg, D, Rodrigo, L & Kruzliak, P 2017, 'Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders', Biomedicine and Pharmacotherapy, vol. 91, pp. 60-69. https://doi.org/10.1016/j.biopha.2017.04.034
Caprnda, Martin ; Kubatka, Peter ; Gazdikova, Katarina ; Gasparova, Iveta ; Valentova, Vanda ; Stollarova, Nadezda ; La Rocca, Giampiero ; Kobyliak, Nazarii ; Dragasek, Jozef ; Mozos, Ioana ; Prosecky, Robert ; Siniscalco, Dario ; Busselberg, Dietrich ; Rodrigo, Luis ; Kruzliak, Peter. / Immunomodulatory effects of stem cells : Therapeutic option for neurodegenerative disorders. In: Biomedicine and Pharmacotherapy. 2017 ; Vol. 91. pp. 60-69.
@article{5b053c7788c14329abf97abcd54e2738,
title = "Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders",
abstract = "Stem cells have the capability of self-renewal and can differentiate into different cell types that might be used in regenerative medicine. Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) currently lack effective treatments. Although stem cell therapy is still on the way from bench to bedside, we consider that it might provide new hope for patients suffering with neurodegenerative diseases. In this article, we will give an overview of recent studies on the potential therapeutic use of mesenchymal stem cells (MSCs), neural stem cells (NSCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and perinatal stem cells to neurodegenerative disorders and we will describe their immunomodulatory mechanisms of action in specific therapeutic modalities.",
keywords = "Neurodegenerative disorders, Regenerative medicine, Stem cell therapy",
author = "Martin Caprnda and Peter Kubatka and Katarina Gazdikova and Iveta Gasparova and Vanda Valentova and Nadezda Stollarova and {La Rocca}, Giampiero and Nazarii Kobyliak and Jozef Dragasek and Ioana Mozos and Robert Prosecky and Dario Siniscalco and Dietrich Busselberg and Luis Rodrigo and Peter Kruzliak",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.biopha.2017.04.034",
language = "English",
volume = "91",
pages = "60--69",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Immunomodulatory effects of stem cells

T2 - Therapeutic option for neurodegenerative disorders

AU - Caprnda, Martin

AU - Kubatka, Peter

AU - Gazdikova, Katarina

AU - Gasparova, Iveta

AU - Valentova, Vanda

AU - Stollarova, Nadezda

AU - La Rocca, Giampiero

AU - Kobyliak, Nazarii

AU - Dragasek, Jozef

AU - Mozos, Ioana

AU - Prosecky, Robert

AU - Siniscalco, Dario

AU - Busselberg, Dietrich

AU - Rodrigo, Luis

AU - Kruzliak, Peter

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Stem cells have the capability of self-renewal and can differentiate into different cell types that might be used in regenerative medicine. Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) currently lack effective treatments. Although stem cell therapy is still on the way from bench to bedside, we consider that it might provide new hope for patients suffering with neurodegenerative diseases. In this article, we will give an overview of recent studies on the potential therapeutic use of mesenchymal stem cells (MSCs), neural stem cells (NSCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and perinatal stem cells to neurodegenerative disorders and we will describe their immunomodulatory mechanisms of action in specific therapeutic modalities.

AB - Stem cells have the capability of self-renewal and can differentiate into different cell types that might be used in regenerative medicine. Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS) currently lack effective treatments. Although stem cell therapy is still on the way from bench to bedside, we consider that it might provide new hope for patients suffering with neurodegenerative diseases. In this article, we will give an overview of recent studies on the potential therapeutic use of mesenchymal stem cells (MSCs), neural stem cells (NSCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and perinatal stem cells to neurodegenerative disorders and we will describe their immunomodulatory mechanisms of action in specific therapeutic modalities.

KW - Neurodegenerative disorders

KW - Regenerative medicine

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=85018605782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018605782&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.04.034

DO - 10.1016/j.biopha.2017.04.034

M3 - Review article

VL - 91

SP - 60

EP - 69

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

ER -